Skip to content

EASL DeepDive: The Pursuit of a Cure: HCC Management Strategies

April 9, 2026 · 1 h 15 min

Show notes

Hepatocellular carcinoma (HCC) is responsible for 75% of all primary liver cancers and is the third most prevalent cause of cancer death worldwide, with 900,000 new cases diagnosed each year. Many patients are diagnosed at an advanced stage, making curative treatment difficult.

In this DeepDive Webinar, you’ll be guided through the latest advances in hepatocellular carcinoma management, from the rising impact of immunotherapy combinations to evolving approaches in intermediate-stage disease.

This EASL DeepDive webinar is supported by Bayer AG. Bayer AG has had no input into the content of this EASL DeepDive.

Learning Objectives

  • What are strategies to optimise surveillance and early diagnosis of hepatocellular carcinoma
  • What are the optimal candidates for surgery (including liver transplantation) and locoregional therapies (alone or combined with immunotherapy)
  • Optimal selection of systemic front-line regimens and treatment sequencing after first-line immunotherapy

Faculty

  • Manon Allaire - Moderator
  • Fabio Piscaglia - Speaker
  • Antonio D'Alessio - Speaker
  • Anna Saborowski - Speaker

All episodes of EASL Podcasts

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.